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Acute cholecystitis is a major health problem. There are multiple etiologies to be considered and early recognition of the
condition is important to optimize management and outcome. We report the ﬁrst case in the medical literature of symptomatic
acute cholecystitis triggered by ceftriaxone-associated gallbladder sludge formation and, importantly, solid ceftriaxone gallstone
formation in an adult patient with underlying mineral and pigment cholecystolithiasis, necessitating cholecystectomy. This case
serves as a reminder for physicians to keep this uncommon cause of cholecystolithiasis and cholecystitis in mind in patients who
receive prolonged ceftriaxone therapy. These patients should be cautioned to promptly report to their physicians any signs or
symptoms of cholecystitis in order to ensure timely and appropriate evaluation.
Copyright © 2009 C. D. Becker and R. A. Fischer. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Background
Acute cholecystitis is a major health problem. There are
multiple etiologies to be considered and early recognition
of the condition is important to optimize management and
outcome.
2.CaseReport
A-68-year-old African-American male was admitted for 2
days of worsening right upper quadrant abdominal pain.
The pain was constant, noncolicky, nonradiating, 6–8/10
in intensity, accompanied by nausea and vomiting with
attempted food intake. No fevers or chills were present.
9 weeks prior to admission the patient underwent
craniotomyfordrainageofmultiplebrainabscesses.Cultures
were negative. Long-term empiric therapy with high doses
of ceftriaxone (2gm i.v. q12 hours), caspofungin (50mg
i.v. q24 hours), metronidazole (500mg p.o. q8 hours), and
corticosteroids was initiated at that time.
Physical examination revealed marked right upper quad-
rant tenderness and a positive Murphy’s sign. Laboratory
data showed a normal white blood cell count of 5400/mm3,
hemoglobin of 10.3g/dL, normal blood chemistry values
except a blood glucose of 157mg/dL. The total bilirubin was
normal at 0.2mg/dL, the alkaline phosphatase was slightly
elevated at 177IU/L. The transaminases were normal (AST
21IU/L, ALT 14IU/L).
A CT scan revealed gallbladder wall thickening, peric-
holecystic ﬂuid, and multiple gallstones in the gallbladder.
The patient underwent cholecystectomy on the day
of admission. The gallbladder contained numerous green-
yellow gallstones of various sizes (see Figure 1), which were
soft and easily compressible.
The patient experienced an uncomplicated postoperative
course.
The prolonged treatment with high doses of ceftriaxone
and peculiar consistency of the gallstones resulted in the
clinical suspicion of ceftriaxone-associated gallstones.There-
fore, a gallstone sample was analyzed by high-pressure liquid
chromatography [1]. The sample contained 70.4% minerals,
7.5% pigments, and 0.1% cholesterol as well as signiﬁcant
amounts of ceftriaxone calcium salt (mean of 22%, with 3
separate measurements of 20.97%, 23.43%, and 21.59%).
3. Discussion
Ceftriaxone is 10–40% hepatically eliminated [2] and is
known to induce reversible precipitates of ceftriaxone cal-
cium in the gallbladder [3]. Ultrasonographically, these2 Case Reports in Medicine
Figure 1: Surgical specimen (gallbladder, with resection clips)
showing a large number of greenish-brownish gallstones of various
sizes and “crumbly” consistency.
precipitates resemble gallbladder sludge, but the ultrasound-
morphologic similarity to gallstones as well as the rapid dis-
appearance after discontinuation of ceftriaxone has resulted
in the term “ceftriaxone pseudolithiasis.”
The phenomena of ceftriaxone-associated sludge for-
mation and ceftriaxone-associated cholelithiasis are well
documented in the pediatric literature and have resulted
in unnecessary cholecystectomies in pediatric patients. The
incidence of ceftriaxone sludge formation in patients treated
with ceftriaxone ranges from 25% to 46%, but only a
minority of these patients become symptomatic [4].
A Medline search with the terms (“ceftriaxone” AND
(“acute cholecystitis” OR “cholecystolithiasis”)) from 1980
to 2008 revealed one report of ceftriaxone-associated chole-
cystolithiasis leading to acute gallstone pancreatitis in a 42-
year-old male [5], but no reports of ceftriaxone-associated
cholecystolithiasis with acute cholecystitis in adults.
However, there are several reports of coexisting cholecys-
tolithiasis in patients with ceftriaxone-associated gallbladder
sludge formation. There are three mechanisms by which a
patient receiving ceftriaxone can develop acute cholecystitis:
ceftriaxone-associated sludge can trigger existing gallstones
to become symptomatic, ceftriaxone pseudolithiasis can
transform into ceftriaxone gallstones, or the patient can
become symptomatic from preexisting cholecystolithiasis
unrelated to ceftriaxone therapy.
Because of the unusual appearance and consistency of
the stones in our patient and the analysis showing that
ceftriaxone was incorporated into the stones in signiﬁcant
amounts, we believe that ceftriaxone therapy was responsible
for the development of acute cholecystitis in our patient.
4. Conclusion
We report the ﬁrst case in the medical literature of
symptomatic acute cholecystitis triggered by ceftriaxone-
associated gallbladder sludge formation and, importantly,
solid ceftriaxone gallstone formation in an adult patient
with underlying mineral and pigment cholecystolithiasis,
necessitating cholecystectomy.
This case serves as a reminder for physicians to keep this
uncommon cause of cholecystolithiasis and cholecystitis in
mind in patients who receive prolonged ceftriaxone therapy.
These patients should be cautioned to promptly report to
their physicians any signs or symptoms of cholecystitis in
order to ensure timely and appropriate evaluation.
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